Black Hawk Acquisition says 2,089,162 shares redeemed in Vesicor deal, cutting trust to about $420,377

Black Hawk Acquisition is seeking to merge with Vesicor Therapeutics, with redemptions tied to the proposed business combination. Holders redeemed 2,089,162 Class A ordinary shares for about $25.15 million. Roughly 2,060,000 Class A ordinary shares are expected to remain outstanding, including shares not subject to redemption. About $420,377 is estimated to remain in the trust account, pending final reconciliation and adjustment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Black Hawk Acquisition Corporation published the original content used to generate this news brief via (Ref. ID: 202610140600PRIMZONEFULLFEED9845379) on October 14, 2026, and is solely responsible for the information contained therein. (C)